DP
AMGN icon

Dearborn Partners’s Amgen AMGN Stock Holding History

Dearborn Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$691K Sell
1,964
-639
-25% -$228K 0.04% 157
2025
Q4 		$852K Buy
2,603
+40
+2% +$12.7K 0.04% 135
2025
Q3 		$723K Sell
2,563
-106
-4% -$30.7K 0.03% 150
2025
Q2 		$745K Buy
2,669
+570
+27% +$161K 0.04% 144
2025
Q1 		$654K Sell
2,099
-1,639
-44% -$484K 0.03% 140
2024
Q4 		$974K Buy
3,738
+160
+4% +$47.5K 0.04% 121
2024
Q3 		$1.15M Buy
3,578
+199
+6% +$65.1K 0.05% 112
2024
Q2 		$1.06M Buy
3,379
+592
+21% +$174K 0.05% 114
2024
Q1 		$792K Sell
2,787
-811
-23% -$237K 0.03% 130
2023
Q4 		$1.04M Buy
3,598
+71
+2% +$19.3K 0.04% 113
2023
Q3 		$948K Buy
3,527
+535
+18% +$134K 0.04% 108
2023
Q2 		$664K Buy
2,992
+198
+7% +$45.9K 0.03% 131
2023
Q1 		$675K Sell
2,794
-1,226
-30% -$301K 0.03% 130
2022
Q4 		$1.06M Sell
4,020
-1,097
-21% -$294K 0.04% 111
2022
Q3 		$1.15M Buy
5,117
+60
+1% +$14.5K 0.05% 103
2022
Q2 		$1.23M Buy
5,057
+174
+4% +$42.6K 0.05% 105
2022
Q1 		$1.18M Buy
4,883
+117
+2% +$26.9K 0.04% 114
2021
Q4 		$1.07M Buy
4,766
+714
+18% +$151K 0.04% 115
2021
Q3 		$862K Buy
4,052
+167
+4% +$38.4K 0.04% 122
2021
Q2 		$947K Buy
3,885
+795
+26% +$196K 0.04% 120
2021
Q1 		$769K Sell
3,090
-1,020
-25% -$243K 0.03% 124
2020
Q4 		$945K Sell
4,110
-160
-4% -$36.9K 0.04% 111
2020
Q3 		$1.08M Buy
4,270
+26
+0.6% +$6.44K 0.05% 102
2020
Q2 		$1M Buy
4,244
+33
+0.8% +$7.53K 0.05% 97
2020
Q1 		$854K Sell
4,211
-565
-12% -$123K 0.05% 98
2019
Q4 		$1.15M Buy
4,776
+1,417
+42% +$312K 0.06% 95
2019
Q3 		$650K Buy
3,359
+250
+8% +$48K 0.04% 112
2019
Q2 		$573K Buy
3,109
+816
+36% +$146K 0.04% 115
2019
Q1 		$436K Sell
2,293
-1,617
-41% -$309K 0.03% 123
2018
Q4 		$761K Sell
3,910
-897
-19% -$175K 0.06% 100
2018
Q3 		$996K Buy
4,807
+592
+14% +$117K 0.07% 90
2018
Q2 		$778K Buy
4,215
+403
+11% +$71.3K 0.06% 91
2018
Q1 		$650K Sell
3,812
-92
-2% -$16.9K 0.05% 98
2017
Q4 		$679K Hold
3,904
– – 0.05% 97
2017
Q3 		$728K Sell
3,904
-58
-1% -$10.3K 0.05% 92
2017
Q2 		$682K Buy
3,962
+100
+3% +$16.3K 0.05% 98
2017
Q1 		$634K Buy
3,862
+39
+1% +$6.48K 0.05% 104
2016
Q4 		$559K Sell
3,823
-77
-2% -$11.6K 0.05% 103
2016
Q3 		$651K Hold
3,900
– – 0.05% 110
2016
Q2 		$593K Buy
3,900
+400
+11% +$62.2K 0.05% 111
2016
Q1 		$525K Hold
3,500
– – 0.05% 115
2015
Q4 		$568K Hold
3,500
– – 0.05% 146
2015
Q3 		$484K Hold
3,500
– – 0.05% 154
2015
Q2 		$537K Sell
3,500
-1,600
-31% -$256K 0.05% 154
2015
Q1 		$815K Hold
5,100
– – 0.07% 177
2014
Q4 		$812K Hold
5,100
– – 0.07% 176
2014
Q3 		$716K Hold
5,100
– – 0.07% 187
2014
Q2 		$604K Hold
5,100
– – 0.06% 195
2014
Q1 		$629K Hold
5,100
– – 0.07% 191
2013
Q4 		$582K Hold
5,100
– – 0.07% 199
2013
Q3 		$571K Sell
5,100
-212
-4% -$23K 0.08% 195
2013
Q2 		$524K Buy
+5,312
New +$551K 0.07% 196

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dearborn Partners's AMGN Position: Q1 2026 in Review

Dearborn Partners reduced its Amgen (AMGN) stake by 25% in Q1 2026, selling an estimated $228K and leaving 1,964 shares worth $691K. The position accounts for 0.04% of the portfolio, ranked #157.

Dearborn Partners first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23M in Q2 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Dearborn Partners held 1,964 shares of Amgen worth $691K as of Q1 2026.
  • Dearborn Partners sold 639 Amgen shares in Q1 2026, an estimated $228K.
  • Amgen made up 0.04% of Dearborn Partners's portfolio in Q1 2026, its #157 holding.
  • Dearborn Partners first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Dearborn Partners's Amgen position peaked at $1.23M in Q2 2022.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.